Tecan uses cookies to improve our website. By continuing to browse our website, you accept our cookie policy.

This content is available also in other languages

x

This content is available also in other languages

September 28, 2010 | Customer News

From macro to micro with the Tecan Cavro® Mini Sample Processor

From macro to micro with the Tecan Cavro® Mini Sample Processor

Männedorf, Switzerland, September 28, 2010 –  IntegenX, Inc., California, USA, has used Tecan’s Cavro® Mini Sample Processor (MSP) 9250 as the basis for an automated Sanger sequencing sample preparation platform. The Apollo 100 Sanger Sequencing Automation system uses the Cavro MSP 9250 to automate bulk liquid transfers, interfacing directly with IntergenX’s patented MOVe™ microfluidic technology to enable users to work with small volumes, from 10 nanoliters to 100 microliters. James Nelson, Marketing Director at IntegenX, explained: “With Sanger sequencing, the major ‘pain point’ for the researcher is the expense of both the Big Dye® and clean-up reagents. The process is relatively expensive when performed manually, but, once automated with a microfluidics chip, the reagent volumes used can be dramatically reduced, meaning that the initial cost of automation pays for itself through the substantial reagent cost savings generated.”

“Sample volumes for manual methods are typically in milliliters, and the Apollo 100 system provides an easy-to-use interface between the ‘macro world’ and our microfluidic technology that handles microliter to nanoliter volumes. To transfer samples from macro to micro we required a robotic system that was highly reliable and robust. Tecan was a name our customers knew and trusted, and the Cavro MSP matched our needs really well. It was very straightforward to integrate into our system, and Tecan provided all the technical support we needed. We are now planning to incorporate Tecan’s robotic liquid handlers into future products based on our MOVe technology, including exciting solutions in the field of next generation sequencing,” Mr. Nelson concluded.

To find out more on Tecan’s Cavro MSP platform, visit http://www.tecan.com/CavroMSP

To find out more on IntegenX, Inc., visit http://www.integenx.com

Big Dye is a registered trademark of Life Technologies, Inc.

 

For more information please contact

Tecan Trading AG
Tanja Kaiser
Seestrasse 103
CH-8708 Männedorf

Tel +41 (0)44 922 81 11
Fax +41 (0)44 922 81 12

info@tecan.com
www.tecan.com


About Tecan

Tecan (www.tecan.com) is a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics. The company specializes in the development, production and distribution of instruments and automated workflow solutions for laboratories in the life sciences sector. As an original equipment manufacturer, Tecan is also a leader in developing and manufacturing OEM instruments and components that are then distributed by partner companies. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both Europe and North America and maintains a sales and service network in 52 countries. In 2009, Tecan generated sales of CHF 392 million (USD 361.2 million; EUR 259.6 million). Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TK: TECN/Reuters: TECZn.S/ ISIN CH0012100191).


About IntegenX Inc.

IntegenX, Inc. (IXI), headquartered in Pleasanton, CA is a venture-backed, privately held company that produces sample processing systems for life sciences, applied sciences, and healthcare diagnostics research markets. The company's products integrate advanced fluidics and analytical capabilities to produce automated sample-to-answer systems for DNA and RNA sequencing, DNA-based forensics and human identity (HID) testing, biodefense, and molecular diagnostics research. The company's first product, the Apollo 100 System, completely automates sample processing for Sanger cycle sequencing and dramatically reduces process requirements for expensive sequencing reagents. For additional information about IXI, visit www.integenx.com.